⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NBP News
NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences Appoints Chuck Silberstein as Chief Financial Officer
globenewswire.com
NBP
NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development
globenewswire.com
NBP
Visara Secures Exclusive Option for Potential Acquisition of YOL104-2 for Ocular Surface Squamous Neoplasia
globenewswire.com
NBP
Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis
globenewswire.com
NBP
Hiteck Licenses Investigational Next-Generation NGF Eye Drop HT006.2.2 to Visara for Neurotrophic Keratitis Outside Greater China
prnewswire.com
NBP
NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026
globenewswire.com
NBP
NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director
globenewswire.com
NBP
TTRX
NovaBridge Biosciences to Participate in September Investor Conferences
globenewswire.com
NBP
BMW i Ventures, Bosch Ventures, Hitachi Ventures, Yamaha Motor Ventures, Lead Strategic Investment in Nauta, the operational brain powering autonomous AI agents for global trade
globenewswire.com
NBP
NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution
globenewswire.com
NBP